193
Views
0
CrossRef citations to date
0
Altmetric
Review

Promotor methylation in ocular surface squamous neoplasia development: epigenetics implications in molecular diagnosis

ORCID Icon, , & ORCID Icon
Pages 753-769 | Received 05 Feb 2023, Accepted 20 Jul 2023, Published online: 07 Aug 2023
 

ABSTRACT

Introduction

Cancer is heavily influenced by epigenetic mechanisms that include DNA methylation, histone modifications, and non-coding RNA. A considerable proportion of human malignancies are believed to be associated with global DNA hypomethylation, with localized hypermethylation at promoters of certain genes.

Area covered

The present review aims to emphasize on recent investigations on the epigenetic landscape of ocular surface squamous neoplasia, that could be targeted/explored using novel approaches such as personalized medicine.

Expert opinion

While the former is thought to contribute to genomic instability, promoter-specific hypermethylation might facilitate tumorigenesis by silencing tumor suppressor genes. Ocular surface squamous neoplasia, the most prevalent type of ocular surface malignancy, is suggested to be affected by epigenetic mechanisms, as well. Although the exact role of epigenetics in ocular surface squamous neoplasia has mostly been unexplored, recent findings have greatly contributed to our understanding regarding this pathology of the eye.

Article highlights

  • Nanodevices can be used as diagnostic platforms for identification of distinct epigenetic changes associated with different diseases, particularly neoplasms such as OSSN.

  • Recent investigations have highlighted the role of epigenetic mechanisms including histone modifications and DNA methylation in the pathogenesis of OSSN.

  • Roughly 40% of the mammalian genome is made of CpG islands, which are methylated or demethylated by corresponding enzymes to regulate gene expression.

  • Development and application of nanodevices for identification of OSSN-related DNA methylation can assist clinicians with developing screening and diagnostic programs.

Abbreviations

5mC=

5-methylcytosine

3’UTR=

3’ untranslated region

Affymetrix=

applied microarray analysis

aCGH=

array-based Comparative Genomic Hybridization

AMD=

age-related macular degeneration

BAP1=

BRCA1-associated protein-1

BSS=

bisulfite sequencing

CDK=

cyclin-dependent kinase

CDK4=

cyclin-dependent kinase 4

CDK6=

cyclin-dependent kinase 6

CIN=

intraepithelial neoplastic lesions

CGH=

Comparative Genomic Hybridization

CIN 1=

conjunctival intraepithelial neoplasia 1

CIN 2=

conjunctival intraepithelial neoplasia 2

CIN 3=

conjunctival intraepithelial neoplasia 3

CMs=

conjunctival melanoma samples

CpG=

5‘—C – phosphate—G—3’

CSCC=

conjunctival squamous cell carcinoma

CT=

computed tomography

DNMTs=

DNA methyltransferases

DNMT1=

DNA methyltransferase 1

DNMT3A=

DNA methyltransferase 3A

DNMT3B=

DNA methyltransferase 3B

DNMT3L=

DNA methyltransferase 3-like

E-MSP=

specific electrochemical methylation-specific polymerase chain reaction

GNAQ=

guanine nucleotide-binding protein G subunit

HATs=

histone lysine acetyltransferases

HDACs=

histone deacetylases

HIV=

immunodeficiency virus

HPV=

human papilloma virus

HR-OCT=

high-resolution optical coherence tomography

HSP90=

heat shock protein 90

HSV-1=

herpes simplex virus 1

IHC=

immunohistochemical

IVCM=

In vivo confocal microscopy

LncRNAs=

long non-coding RNAs

MAPK=

mitogen-activated protein kinase

miRNAs=

microRNAs

MMP-9=

matrix metalloproteinase 9

MMP-11=

matrix metalloproteinase 11

MRI=

magnetic resonance imaging

MS-HRM=

methylation-sensitive high-resolution melting analysis

MS-MPLA=

Methylation-specific multiplex ligation-dependent probe amplification

MSP-PCR=

Methylation-specific PCR

ncRNAs=

non-coding RNAs

OCT=

optical coherence tomography

OS=

ocular surface

OSSN=

Ocular surface squamous neoplasia

qMSP=

quantitative MSP

qPCR=

quantitative real-time PCR

Real-time PCR=

quantitative real-time polymerase chain reaction

RNase III=

Ribonuclease III

ROP=

early retinopathy

SCC=

squamous cell carcinoma

SiRNAs=

small interfering RNAs

SIRT1=

sirtuin 1

TET=

ten-eleven translocation

TSGs=

tumor suppressor genes

UBM=

ultrasound biomicroscopy

UHR=

ultra high resolution

UV=

Ultraviolet

VEGF=

vascular endothelial growth factor

VM=

vasculogenic mimicry

Declaration of interest

The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

Reviewers disclosure

Peer reviewers on this manuscript have no relevant financial relationships or otherwise to disclose.

Additional information

Funding

This paper was not funded.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 99.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 706.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.